Scientists scan brains to understand how cannabinoid receptors work in mental illness and addiction

NCT ID NCT01730781

First seen Apr 29, 2026 · Last updated May 12, 2026 · Updated 3 times

Summary

This study uses PET brain scans to measure cannabinoid receptors in healthy volunteers and people with conditions like schizophrenia, cannabis dependence, PTSD, and opioid use disorder. The goal is to understand how these receptors differ across conditions and over time. Participants may have one or more scans, and cannabis users will be scanned after smoking as usual, after 48 hours of abstinence, and after 4 weeks of abstinence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Connecticut Mental Health Center, Clinical Neuroscience Research Unit

    RECRUITING

    New Haven, Connecticut, 06519, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.